PT  - JOURNAL ARTICLE
AU  - Shuman, Jill
TI  - Safety and Efficacy of Dupilumab in Adults with Chronic AD
DP  - 2014 Dec 01
TA  - MD Conference Express
PG  - 13--13
VI  - 14
IP  - 37
4099  - http://mdc.sagepub.com/content/14/37/13.1.short
4100  - http://mdc.sagepub.com/content/14/37/13.1.full
AB  - Atopic dermatitis (AD) is a common, chronic skin condition induced by a type 2 helper T cell-mediated response to various environmental antigens. These cells release cytokines that promote occurrence and recurrence of AD. This article reviews safety and efficacy results from the phase 2b Study of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis [NCT01859988].